Laurence H. Beck MD, PhD

Associate Professor, Nephrology

Graduate Faculty (Primary Mentor of Grad Students)

650 Albany St | (617) 638-7330
Laurence Beck
Sections

Nephrology

Centers

Evans Center for Interdisciplinary Biomedical Research

Biography

Laurence H. Beck, Jr., MD, PhD, completed his Internal Medicine residency and Nephrology fellowship at Boston Medical Center. He joined the Renal Section in 2006, and continues to conduct basic science research in the laboratory of Dr. David Salant on the pathogenesis of membranous nephropathy. His clinical roles include a weekly clinic and attending time on the consult and dialysis/transplant services. He also has expertise in immune-mediated glomerular disease.

Education

Medicine-Internal, MD, Harvard Medical School

Cell & Molecular Biology, PhD, Harvard University

Cell & Molecular Biology, BA, Princeton University

Publications

Published on 4/10/2025

Jeyabalan A, Czawlytko CL, Beck LH, Trivin-Avillach C. Case 10-2025: A 32-Year-Old Woman with Flank Pain, Fever, and Hypoxemia. N Engl J Med. 2025 Apr 10; 392(14):1428-1437. PMID: 40214035.

Published on 4/8/2025

Avasare RS, Andeen NK, Al-Rabadi LF, Burfeind KG, Beck LH. Drug-Induced Membranous Nephropathy: Piecing Together Clues to Understand Disease Mechanisms. J Am Soc Nephrol. 2025 Apr 08. PMID: 40198910.

Published on 3/17/2025

Schmidt IM, Verma A, Claudel SE, Palsson R, Srivastava A, Stillman IE, Beck LH, Waikar SS. Genetic Testing in Biopsy-Confirmed Kidney Disease. Kidney Med. 2025 May; 7(5):100994. PMID: 40321977.

Published on 3/14/2025

Prunotto M, Nachman PH, Gillespie BS, Beck LH, Thompson AM, Hu AH, Stafford EA, Tarnoff JM, Rovin BH. Designing Clinical Trials for the Treatment of Membranous Nephropathy in the Anti-Phospholipase A2 Receptor 1 Era: Results of a NephCure Membranous Nephropathy Workshop. Glomerular Dis. 2025; 5(1):133-141. PMID: 40092585.

Published on 3/14/2025

Prunotto M, Nachman PH, Gillespie BS, Beck LH, Thompson AM, Hu AH, Stafford EA, Tarnoff JM, Rovin BH. Designing clinical trials for the treatment of membranous nephropathy in the anti-PLA2R era: results of a Nephcure membranous nephropathy workshop. Kidney Int. 2025 May; 107(5):809-815. PMID: 40088237.

Published on 2/28/2025

Zee J, Hogan JJ, Abdullah A, Liu L, Kiryluk K, Beck LH. Noninvasive Diagnostic Strategies for Membranous Nephropathy in the Nephrotic Syndrome Study Network. Clin J Am Soc Nephrol. 2025 May 01; 20(5):697-705. PMID: 40019793.

Published on 1/16/2025

Hayashi N, Kumar S, Trivin-Avillach C, Fan X, Stoddard SV, Akai R, Fujimoto K, Iwawaki T, Yokoyama H, Furuichi K, Beck LH. Characterization of FAM114A1: a novel podocyte cytoskeleton-associated protein upregulated in glomerular injury. Am J Physiol Renal Physiol. 2025 Feb 01; 328(2):F289-F299. PMID: 39819080.

Published on 10/21/2024

Al-Rabadi LF, Storey A, Larsen CP, Hassen SI, Revelo MP, Singh RS, Lazar-Molnar E, Jain D, Ibrahim A, Darras F, Salam R, Al-Rabadi A, Wikan N, Redecke V, Talwar M, Haecker H, Beck LH, Caza TN. De novo Membranous Nephropathy in Renal Allografts is Associated With Protocadherin FAT1. Kidney Int Rep. 2025 Jan; 10(1):247-251. PMID: 39810776.

Published on 7/1/2024

Bharati J, Waguespack DR, Beck LH. Membranous Nephropathy: Updates on Management. Adv Kidney Dis Health. 2024 Jul; 31(4):299-308. PMID: 39084755.

Published on 6/4/2024

Vivarelli M, Barratt J, Beck LH, Fakhouri F, Gale DP, Goicoechea de Jorge E, Mosca M, Noris M, Pickering MC, Susztak K, Thurman JM, Cheung M, King JM, Jadoul M, Winkelmayer WC, Smith RJH. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2024 Sep; 106(3):369-391. PMID: 38844295.

View full list of 107 publications.